Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 369

1.

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.

Lo Re V 3rd, Kallan MJ, Tate JP, Localio AR, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park L, Dubrow R, Reddy KR, Kostman JR, Strom BL, Justice AC.

Ann Intern Med. 2014 Mar 18;160(6):369-79. doi: 10.7326/M13-1829.

2.

Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans.

Anderson JP, Tchetgen Tchetgen EJ, Lo Re V 3rd, Tate JP, Williams PL, Seage GR 3rd, Horsburgh CR, Lim JK, Goetz MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Klein MB, Justice AC.

Clin Infect Dis. 2014 Mar;58(5):719-27. doi: 10.1093/cid/cit779. Epub 2013 Nov 27.

3.

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Lo Re V 3rd, Volk J, Newcomb CW, Yang YX, Freeman CP, Hennessy S, Kostman JR, Tebas P, Leonard MB, Localio AR.

Hepatology. 2012 Nov;56(5):1688-98. doi: 10.1002/hep.25866. Epub 2012 Oct 14.

4.

Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.

Fernández-Montero JV, Vispo E, Barreiro P, Sierra-Enguita R, de Mendoza C, Labarga P, Soriano V.

Clin Infect Dis. 2014 Jun;58(11):1549-53. doi: 10.1093/cid/ciu167. Epub 2014 Mar 14.

PMID:
24633686
5.

The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.

Kramer JR, Kowalkowski MA, Duan Z, Chiao EY.

J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):456-62. doi: 10.1097/QAI.0000000000000494.

6.

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.

Mussini C, Lorenzini P, Puoti M, Lichtner M, Lapadula G, Di Giambenedetto S, Antinori A, Madeddu G, Cozzi-Lepri A, d'Arminio Monforte A, De Luca A; ICONA Foundation Study Group..

PLoS One. 2015 Dec 7;10(12):e0140877. doi: 10.1371/journal.pone.0140877. eCollection 2015.

7.

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.

Loko MA, Salmon D, Carrieri P, Winnock M, Mora M, Merchadou L, Gillet S, Pambrun E, Delaune J, Valantin MA, Poizot-Martin I, Neau D, Bonnard P, Rosenthal E, Barange K, Morlat P, Lacombe K, Gervais A, Rouges F, See AB, Lascoux-Combe C, Vittecoq D, Goujard C, Duvivier C, Spire B, Izopet J, Sogni P, Serfaty L, Benhamou Y, Bani-Sadr F, Dabis F; ANRS CO 13 HEPAVIH Study Group..

BMC Infect Dis. 2010 Oct 22;10:303. doi: 10.1186/1471-2334-10-303.

8.

Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.

García-García JA, Romero-Gómez M, Girón-González JA, Rivera-Irigoin R, Torre-Cisneros J, Montero JL, González-Serrano M, Andrade RJ, Aguilar-Guisado M, Grilo I, Martín-Vivaldi J, Salmerón J, Caballero-Granado FJ, Macías J, Vergara-López S, Pineda JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas (GAEI).; Grupo Andaluz para el Estudio del Hígado (GAEH)..

AIDS Res Hum Retroviruses. 2006 Dec;22(12):1236-41.

PMID:
17209765
9.

Reversible hepatic decompensation following cessation of antiretroviral therapy in a patient with HIV and hepatitis C co-infection.

Croucher AP, Main J.

Int J STD AIDS. 2014 Sep;25(10):762-4. doi: 10.1177/0956462414521401. Epub 2014 Jan 29.

PMID:
24478027
10.

Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.

Lim JK, Tate JP, Fultz SL, Goulet JL, Conigliaro J, Bryant KJ, Gordon AJ, Gibert C, Rimland D, Goetz MB, Klein MB, Fiellin DA, Justice AC, Lo Re V 3rd.

Clin Infect Dis. 2014 May;58(10):1449-58. doi: 10.1093/cid/ciu097. Epub 2014 Feb 25.

11.

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

Pineda JA, Aguilar-Guisado M, Rivero A, Girón-González JA, Ruiz-Morales J, Merino D, Ríos-Villegas MJ, Macías J, López-Cortés LF, Camacho A, Merchante N, Del Valle J; Grupo para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas..

Clin Infect Dis. 2009 Oct 15;49(8):1274-82. doi: 10.1086/605676.

PMID:
19772387
12.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord..

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.

PMID:
23583272
13.

Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients.

Labarga P, Fernandez-Montero JV, de Mendoza C, Barreiro P, Pinilla J, Soriano V.

Antivir Ther. 2015;20(3):329-34. doi: 10.3851/IMP2909. Epub 2014 Nov 5.

PMID:
25372299
14.

Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.

Lo Re V 3rd, Wang L, Devine S, Baser O, Olufade T.

Clin Infect Dis. 2014 Oct;59(7):1027-31. doi: 10.1093/cid/ciu476. Epub 2014 Jun 18.

PMID:
24944235
15.

Hepatitis B or hepatitis C coinfection in HIV-infected pregnant women in Europe.

Landes M, Newell ML, Barlow P, Fiore S, Malyuta R, Martinelli P, Posokhova S, Savasi V, Semenenko I, Stelmah A, Tibaldi C, Thorne C.

HIV Med. 2008 Aug;9(7):526-34. doi: 10.1111/j.1468-1293.2008.00599.x. Epub 2008 Jun 28.

16.

Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.

Marcus JL, Leyden WA, Chao CR, Xu L, Quesenberry CP Jr, Tien PC, Klein DB, Towner WJ, Horberg MA, Silverberg MJ.

AIDS Patient Care STDS. 2015 Jul;29(7):370-8. doi: 10.1089/apc.2015.0040. Epub 2015 May 18.

17.

Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.

Fernández-Montero JV, Barreiro P, de Mendoza C, Labarga P, Soriano V.

J Viral Hepat. 2016 Jan;23(1):47-52. doi: 10.1111/jvh.12447. Epub 2015 Sep 21.

PMID:
26390144
18.
19.

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus.

Singal AG, Volk ML, Jensen D, Di Bisceglie AM, Schoenfeld PS.

Clin Gastroenterol Hepatol. 2010 Mar;8(3):280-8, 288.e1. doi: 10.1016/j.cgh.2009.11.018. Epub 2009 Nov 27.

PMID:
19948249
20.

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.

Molina JM, Orkin C, Iser DM, Zamora FX, Nelson M, Stephan C, Massetto B, Gaggar A, Ni L, Svarovskaia E, Brainard D, Subramanian GM, McHutchison JG, Puoti M, Rockstroh JK; PHOTON-2 study team..

Lancet. 2015 Mar 21;385(9973):1098-106. doi: 10.1016/S0140-6736(14)62483-1. Epub 2015 Feb 4.

PMID:
25659285

Supplemental Content

Support Center